Omega-3 treatment of childhood depression: A controlled, double-blind pilot study

American Journal of Psychiatry

Volumn 163, Issue 6, 2006, Pages 1098-1100

  Nemets, Hanah ^b   Nemets, Boris ^b   Apter, Alan ^b   Bracha, Ziva ^b   Belmaker, R H ^a  

^a MENTAL HEALTH CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; METHYLPHENIDATE; OMEGA 3 FATTY ACID; PLACEBO; EICOSAPENTANOIC ACID; UNSATURATED FATTY ACID;

ANALYSIS OF VARIANCE; ARTICLE; CHILDHOOD DISEASE; CHILDREN DEPRESSION RATING SCALE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION INVENTORY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FISHY TASTE; HUMAN; ISRAEL; MAJOR DEPRESSION; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SYMPTOM; TASTE DISORDER; AGE; CHILD; COMPARATIVE STUDY; DRUG COMBINATION; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

AGE FACTORS; CHILD; DEPRESSIVE DISORDER, MAJOR; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; PERSONALITY INVENTORY; PILOT PROJECTS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 85047698720     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.6.1098     Document Type: Article

References (8)

1. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 1998; 37(10 Suppl):63S-83S
2. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG: Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002; 41:1205-1215
3. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D: Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 2003; 290:1033-1041
4. Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002; 159:477-479
5. Apter A, Orvaschel H, Laseg M, Moses T, Tyano S: Psychometric properties of the K-SADS-P in an Israeli adolescent inpatient population. J Am Acad Child Adolesc Psychiatry 1989; 28:61-65
6. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ: A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003; 160:996-998
7. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE Jr, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J: An overview of recent findings of the Stanley Foundation Bipolar Network (part I). Bipolar Disord 2003; 5:310-319
8. Osher Y, Belmaker RH, Nemets B: Clinical trials of PUFAs in depression: state of the art. Submitted to J Clin Psychiatry